According to Royalty Pharma's latest financial reports the company's current revenue (TTM) is $2.24 B. In 2021 the company made a revenue of $2.28 B an increase over the years 2020 revenue that were of $2.12 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $2.24 B | -1.85% |
2021 | $2.28 B | 7.87% |
2020 | $2.12 B | 16.98% |
2019 | $1.81 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Abbott Laboratories ABT | $45.03 B | 1,903.86% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | $29.23 B | 1,201.17% | ๐บ๐ธ USA |
![]() ANI Pharmaceuticals ANIP | $0.28 B | -87.40% | ๐บ๐ธ USA |